Form 4: Goosehead Insurance Executive Acquires 17,000 Stock Options
SEC Form 4 Filing
John O'Connor, General Counsel of Goosehead Insurance, reports the acquisition of 17,000 employee stock options.
Summary
- John O'Connor, General Counsel of Goosehead Insurance, filed a Form 4 disclosing a transaction.
- On January 2, 2025, Mr. O'Connor acquired 17,000 employee stock options with an exercise price of $115.72.
- These options vest in three equal installments on the first, second, and third anniversaries of the grant date, contingent upon continued employment.
- Full vesting occurs if Mr. O'Connor's employment is terminated without cause or for good reason within six months following a change in control.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants, which is neither overtly positive nor negative.
Positives
- The acquisition of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance, but the vesting schedule of the options is tied to continued employment, suggesting a long-term commitment from the executive.
Industry Context
Executive compensation in the insurance industry often includes stock options to align management's interests with those of shareholders. This grant is a typical component of executive compensation packages.
Comparison to Industry Standards
- Stock option grants are a common practice among publicly traded companies, including insurance firms like Allstate, Progressive, and State Farm.
- The vesting schedules and terms of these grants often vary based on company performance and individual executive agreements.
- Comparing the size and terms of this grant to those of executives at similar-sized insurance companies would provide a better understanding of its competitiveness.
Stakeholder Impact
- The stock option grant aligns the executive's interests with those of shareholders, potentially incentivizing actions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 01/02/2025 | Date of transaction: Acquisition of 17,000 employee stock options. |
| 01/06/2025 | Date of signature on the Form 4 filing. |
| 01/02/2035 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.